[1]

Khazir J, Mir BA, Mir SA, Cowan D. 2013. Natural products as lead compounds in drug discovery. Journal of Asian Natural Products Research 15:764−788

doi: 10.1080/10286020.2013.798314
[2]

Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. Journal of Natural Products 79:629−661

doi: 10.1021/acs.jnatprod.5b01055
[3]

Ferreira MU. 2023. Natural product-derived compounds for targeting multidrug resistance in cancer and microorganisms. International Journal of Molecular Sciences 24:14321

doi: 10.3390/ijms241814321
[4]

Harvey AL, Edrada-Ebel R, Quinn RJ. 2015. The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery 14:111−129

doi: 10.1038/nrd4510
[5]

Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. 2021. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery 20:200−216

doi: 10.1038/s41573-020-00114-z
[6]

von Schwarzenberg K, Vollmar AM. 2013. Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy. Cancer Letters 332:295−303

doi: 10.1016/j.canlet.2010.07.004
[7]

Yao H, Liu J, Xu S, Zhu Z, Xu J. 2017. The structural modification of natural products for novel drug discovery. Expert Opinion on Drug Discovery 12:121−140

doi: 10.1080/17460441.2016.1272757
[8]

Fang J, Liu C, Wang Q, Lin P, Cheng F. 2018. In silico polypharmacology of natural products. Briefings in Bioinformatics 19:1153−1171

doi: 10.1093/bib/bbx045
[9]

Mateus A, Kurzawa N, Perrin J, Bergamini G, Savitski MM. 2022. Drug target identification in tissues by thermal proteome profiling. Annual Review of Pharmacology and Toxicology 62:465−482

doi: 10.1146/annurev-pharmtox-052120-013205
[10]

Brooks CL III, Onuchic JN, Wales DJ. 2001. Taking a walk on a landscape. Science 293:612−613

doi: 10.1126/science.1062559
[11]

Molina DM, Jafari R, Ignatushchenko M, Seki T, Larsson EA, et al. 2013. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341:84−87

doi: 10.1126/science.1233606
[12]

Ruan C, Ning W, Liu Z, Zhang X, Fang Z, et al. 2022. Precipitate-supported thermal proteome profiling coupled with deep learning for comprehensive screening of drug target proteins. ACS Chemical Biology 17:252−262

doi: 10.1021/acschembio.1c00936
[13]

Gummadi SN. 2003. What is the role of thermodynamics on protein stability? Biotechnology and Bioprocess Engineering 8:9−18

doi: 10.1007/BF02932892
[14]

Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundbäck T, et al. 2014. The cellular thermal shift assay for evaluating drug target interactions in cells. Nature Protocols 9:2100−2122

doi: 10.1038/nprot.2014.138
[15]

Martinez Molina D, Nordlund P. 2016. The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies. Annual Review of Pharmacology and Toxicology 56:141−161

doi: 10.1146/annurev-pharmtox-010715-103715
[16]

Gao K, Oerlemans R, Groves MR. 2020. Theory and applications of differential scanning fluorimetry in early-stage drug discovery. Biophysical Reviews 12:85−104

doi: 10.1007/s12551-020-00619-2
[17]

Wu T, Yu JC, Suresh A, Gale-Day ZJ, Alteen MG, et al. 2025. Protein-adaptive differential scanning fluorimetry using conformationally responsive dyes. Nature Biotechnology 43:106−113

doi: 10.1038/s41587-024-02158-7
[18]

Huynh K, Partch CL. 2015. Analysis of protein stability and ligand interactions by thermal shift assay. Current Protocols in Protein Science 79:28.9.1−28.9.14

doi: 10.1002/0471140864.ps2809s79
[19]

Mahran R, Vello N, Komulainen A, Malakoutikhah M, Härmä H, et al. 2023. Isothermal chemical denaturation assay for monitoring protein stability and inhibitor interactions. Scientific Reports 13:20066

doi: 10.1038/s41598-023-46720-w
[20]

Tu Y, Tan L, Tao H, Li Y, Liu H. 2023. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. Phytomedicine 116:154862

doi: 10.1016/j.phymed.2023.154862
[21]

Savitski MM, Reinhard FBM, Franken H, Werner T, Savitski MF, et al. 2014. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science 346:1255784

doi: 10.1126/science.1255784
[22]

Phaneuf CG, Aizikov K, Grinfeld D, Kreutzmann A, Mourad D, et al. 2023. Experimental strategies to improve drug-target identification in mass spectrometry-based thermal stability assays. Communications Chemistry 6:64

doi: 10.1038/s42004-023-00861-1
[23]

Liu X, Salokas K, Tamene F, Jiu Y, Weldatsadik RG, et al. 2018. An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations. Nature Communications 9:1188

doi: 10.1038/s41467-018-03523-2
[24]

Franken H, Mathieson T, Childs D, Sweetman GMA, Werner T, et al. 2015. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nature Protocols 10:1567−1593

doi: 10.1038/nprot.2015.101
[25]

Li F, Zhang Z, Shi Q, Wang R, Ji M, et al. 2025. Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403. Acta Pharmaceutica Sinica B 15:2008−2023

doi: 10.1016/j.apsb.2025.02.027
[26]

Wu Y, Liu H, Wang Q, Zhang T, Chen R, et al. 2025. Neoeriocitrin targeting BECLIN1 deubiquitination and autophagy in osteogenic differentiation of human dental pulp stem cells. Advanced Science 12:e04378

doi: 10.1002/advs.202504378
[27]

Zhang XW, Li L, Liao M, Liu D, Rehman A, et al. 2024. Thermal proteome profiling strategy identifies CNPY3 as a cellular target of gambogic acid for inducing prostate cancer pyroptosis. Journal of Medicinal Chemistry 67:10005−100011

doi: 10.1021/acs.jmedchem.4c00140
[28]

Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, et al. 2009. Target identification using drug affinity responsive target stability (DARTS). Proceedings of the National Academy of Sciences of the United States of America 106:21984−21989

doi: 10.1073/pnas.0910040106
[29]

Tanabe N, Kuboyama T, Tohda C. 2018. Matrine directly activates extracellular heat shock protein 90, resulting in axonal growth and functional recovery in spinal cord injured-mice. Frontiers in Pharmacology 9:446

doi: 10.3389/fphar.2018.00446
[30]

Tang P, Jiang H, Zheng Z, Xiao Z, Kong L, et al. 2026. Limonoid walrobsin A alleviates LPS-induced septic acute kidney injury through modulating inflammatory microenvironment by targeting G protein-coupled receptor 75. Phytomedicine 150:157613

doi: 10.1016/j.phymed.2025.157613
[31]

Jang Y, Ko M, Lee JY, Kim JY, Lee EW, et al. 2025. Inhibition of lysosomal LAMTOR1 increases autophagy by suppressing the MTORC1 pathway to ameliorate lipid accumulations in MAFLD. Autophagy 21:2633−2649

doi: 10.1080/15548627.2025.2519054
[32]

Lai H, Fan P, Zhang P, Zhang M, Li X, et al. 2025. Targeting complement C3 with Tanshinone I decreases microglia-mediated synaptic engulfment to exert antidepressant effects. Theranostics 15:8150−8175

doi: 10.7150/thno.115587
[33]

Yuan J, Tao Y, Wang M, Chen Y, Han X, et al. 2026. Astragaloside II, a natural saponin, facilitates remyelination in demyelination neurological diseases via p75NTR receptor mediated β-catenin/ID2/MBP signaling axis in oligodendrocyte precursor cells. Journal of Advanced Research 80:577−591

doi: 10.1016/j.jare.2025.04.028
[34]

Tao X, Wang H, Wang Q, Wang C, Shao CW, et al. 2025. Marine natural product chagosendine C induces cuproptosis in colorectal cancer cells by targeting FDX1. Journal of the American Chemical Society 147:37089−37103

doi: 10.1021/jacs.5c07917
[35]

Lomenick B, Olsen RW, Huang J. 2011. Identification of direct protein targets of small molecules. ACS Chemical Biology 6:34−46

doi: 10.1021/cb100294v
[36]

Pai MY, Lomenick B, Hwang H, Schiestl R, McBride W, et al. 2015. Drug affinity responsive target stability (DARTS) for small-molecule target identification. In Chemical Biology. Methods in Molecular Biology, Vol. 1263. eds. Hempel J, Williams C, Hong C. New York, NY: Springer. pp. 287−298 doi: 10.1007/978-1-4939-2269-7_22
[37]

Ghaemmaghami S, Fitzgerald MC, Oas TG. 2000. A quantitative, high-throughput screen for protein stability. Proceedings of the National Academy of Sciences of the United States of America 97:8296−8301

doi: 10.1073/pnas.140111397
[38]

West GM, Tang L, Fitzgerald MC. 2008. Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy. Analytical Chemistry 80:4175−4185

doi: 10.1021/ac702610a
[39]

West GM, Tucker CL, Xu T, Park SK, Han X, et al. 2010. Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements. Proceedings of the National Academy of Sciences of the United States of America 107:9078−9082

doi: 10.1073/pnas.1000148107
[40]

Strickland EC, Geer MA, Tran DT, Adhikari J, West GM, et al. 2013. Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation. Nature Protocols 8:148−161

doi: 10.1038/nprot.2012.146
[41]

DeArmond PD, Xu Y, Strickland EC, Daniels KG, Fitzgerald MC. 2011. Thermodynamic analysis of protein-ligand interactions in complex biological mixtures using a shotgun proteomics approach. Journal of Proteome Research 10:4948−4958

doi: 10.1021/pr200403c
[42]

Geer Wallace MA, Kwon DY, Weitzel DH, Lee CT, Stephenson TN, et al. 2016. Discovery of manassantin A protein targets using large-scale protein folding and stability measurements. Journal of Proteome Research 15:2688−2696

doi: 10.1021/acs.jproteome.6b00237
[43]

Xu Y, Wallace MA, Fitzgerald MC. 2016. Thermodynamic analysis of the geldanamycin-HSP90 interaction in a whole cell lysate using a mass spectrometry-based proteomics approach. Journal of the American Society for Mass Spectrometry 27:1670−1676

doi: 10.1007/s13361-016-1457-2
[44]

Geer MA, Fitzgerald MC. 2014. Energetics-based methods for protein folding and stability measurements. Annual Review of Analytical Chemistry 7:209−228

doi: 10.1146/annurev-anchem-071213-020024
[45]

Cowan DA. 1997. Thermophilic proteins: stability and function in aqueous and organic solvents. Comparative Biochemistry and Physiology Part A: Physiology 118:429−438

doi: 10.1016/S0300-9629(97)00004-2
[46]

Zhang X, Wang Q, Li Y, Ruan C, Wang S, et al. 2020. Solvent-induced protein precipitation for drug target discovery on the proteomic scale. Analytical Chemistry 92:1363−1371

doi: 10.1021/acs.analchem.9b04531
[47]

Sun CP, Zhou JJ, Yu ZL, Huo XK, Zhang J, et al. 2022. Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model. Proceedings of the National Academy of Sciences of the United States of America 119:e2118818119

doi: 10.1073/pnas.2118818119
[48]

Yu Z, Gao J, Zhang X, Peng Y, Wei W, et al. 2022. Characterization of a small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal cancer growth. Signal Transduction and Targeted Therapy 7:71

doi: 10.1038/s41392-022-00888-1
[49]

Fontana A, de Laureto PP, Spolaore B, Frare E, Picotti P, et al. 2004. Probing protein structure by limited proteolysis. Acta Biochimica Polonica 51:299−321

doi: 10.18388/abp.2004_3573
[50]

Feng Y, De Franceschi G, Kahraman A, Soste M, Melnik A, et al. 2014. Global analysis of protein structural changes in complex proteomes. Nature Biotechnology 32:1036−1044

doi: 10.1038/nbt.2999
[51]

Malinovska L, Cappelletti V, Kohler D, Piazza I, Tsai TH, et al. 2023. Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications. Nature Protocols 18:659−682

doi: 10.1038/s41596-022-00771-x
[52]

Jiang X, Yeung D, Liu Y, Spicer V, Afshari H, et al. 2024. Accelerating proteomics using broad specificity proteases. Journal of Proteome Research 23:1360−1369

doi: 10.1021/acs.jproteome.3c00852
[53]

Sun B, Liu Z, Liu J, Zhao S, Wang L, et al. 2023. The utility of proteases in proteomics, from sequence profiling to structure and function analysis. Proteomics 23:2200132

doi: 10.1002/pmic.202200132
[54]

Nagel L, Grossbach J, Cappelletti V, Dörig C, Picotti P, et al. 2025. Analysis of limited proteolysis-coupled mass spectrometry data. Molecular & Cellular Proteomics 24:100934

doi: 10.1016/j.mcpro.2025.100934
[55]

Piazza I, Kochanowski K, Cappelletti V, Fuhrer T, Noor E, et al. 2018. A map of protein-metabolite interactions reveals principles of chemical communication. Cell 172:358−372.e323

doi: 10.1016/j.cell.2017.12.006
[56]

Chen S, Liu X, Peng C, Tan C, Sun H, et al. 2021. The phytochemical hyperforin triggers thermogenesis in adipose tissue via a DLAT-AMPK signaling axis to curb obesity. Cell Metabolism 33:565−580.e567

doi: 10.1016/j.cmet.2021.02.007
[57]

Piazza I, Beaton N, Bruderer R, Knobloch T, Barbisan C, et al. 2020. A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes. Nature Communications 11:4200

doi: 10.1038/s41467-020-18071-x
[58]

Leuenberger P, Ganscha S, Kahraman A, Cappelletti V, Boersema PJ, et al. 2017. Cell-wide analysis of protein thermal unfolding reveals determinants of thermostability. Science 355:eaai7825

doi: 10.1126/science.aai7825
[59]

Pepelnjak M, de Souza N, Picotti P. 2020. Detecting protein-small molecule interactions using limited proteolysis-mass spectrometry (LiP-MS). Trends in Biochemical Sciences 45:919−920

doi: 10.1016/j.tibs.2020.05.006
[60]

Tian Y, Wan N, Zhang H, Shao C, Ding M, et al. 2023. Chemoproteomic mapping of the glycolytic targetome in cancer cells. Nature Chemical Biology 19:1480−1491

doi: 10.1038/s41589-023-01355-w
[61]

Yan W, Wang D, Wan N, Wang S, Shao C, et al. 2022. Living cell-target responsive accessibility profiling reveals silibinin targeting ACSL4 for combating ferroptosis. Analytical Chemistry 94:14820−14826

doi: 10.1021/acs.analchem.2c03515
[62]

Zhu Y, Wan N, Shan X, Deng G, Xu Q, et al. 2021. Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice. Acta Pharmaceutica Sinica B 11:1200−1212

doi: 10.1016/j.apsb.2020.12.008
[63]

Deng G, Zhou L, Wang B, Sun X, Zhang Q, et al. 2022. Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation. Journal for ImmunoTherapy of Cancer 10:e004874

doi: 10.1136/jitc-2022-004874
[64]

Li K, Chen S, Wang K, Wang Y, Xue L, et al. 2025. A peptide-centric local stability assay enables proteome-scale identification of the protein targets and binding regions of diverse ligands. Nature Methods 22:278−282

doi: 10.1038/s41592-024-02553-7
[65]

Han S, Li J, Zhu Y, Liu P, Zheng Y, et al. 2026. Halorotetin B, a novel terpenoid compound derived from marine ascidian, suppresses tumor growth by targeting the cell cycle regulator UBE2C. Advanced Science 13:e15652

doi: 10.1002/advs.202515652
[66]

Arwin H. 2000. Ellipsometry on thin organic layers of biological interest: characterization and applications. Thin Solid Films 377−378:48−56

doi: 10.1016/s0040-6090(00)01385-7
[67]

Yao C, Wang T, Zhang B, He D, Na N, et al. 2015. Screening of the binding of small molecules to proteins by desorption electrospray ionization mass spectrometry combined with protein microarray. Journal of the American Society for Mass Spectrometry 26:1950−1958

doi: 10.1007/s13361-015-1221-z
[68]

Zhou Y, Liu Z, Rothschild KJ, Lim MJ. 2016. Proteome-wide drug screening using mass spectrometric imaging of bead-arrays. Scientific Reports 6:26125

doi: 10.1038/srep26125
[69]

Wang Z, Li ZX, Zhao WC, Huang HB, Wang JQ, et al. 2021. Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin B. Acta Pharmacologica Sinica 42:801−813

doi: 10.1038/s41401-020-0491-6
[70]

Chen S, Wang X, Ye X, Ma D, Chen C, et al. 2017. Identification of human UMP/CMP kinase 1 as doxorubicin binding target using protein microarray. SLAS Discovery 22:1007−1015

doi: 10.1177/2472555217707704
[71]

Zhang XW, Feng N, Liu YC, Guo Q, Wang JK, et al. 2022. Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy. Science Advances 8:eabo0789

doi: 10.1126/sciadv.abo0789
[72]

Zhao MM, Ren TT, Wang JK, Yao L, Liu TT, et al. 2025. Endoplasmic reticulum membrane remodeling by targeting reticulon-4 induces pyroptosis to facilitate antitumor immune. Protein & Cell 16:121−135

doi: 10.1093/procel/pwae049
[73]

Hultschig C, Kreutzberger J, Seitz H, Konthur Z, Büssow K, et al. 2006. Recent advances of protein microarrays. Current Opinion in Chemical Biology 10:4−10

doi: 10.1016/j.cbpa.2005.12.011
[74]

Pratsch K, Wellhausen R, Seitz H. 2014. Advances in the quantification of protein microarrays. Current Opinion in Chemical Biology 18:16−20

doi: 10.1016/j.cbpa.2013.10.024
[75]

Zolg DP, Wilhelm M, Schnatbaum K, Zerweck J, Knaute T, et al. 2017. Building ProteomeTools based on a complete synthetic human proteome. Nature Methods 14:259−262

doi: 10.1038/nmeth.4153
[76]

Zhang H, Xie J, Feng Q, Ye J, Chen R, et al. 2023. High resolution micro-confocal Raman spectrometer-based photo-affinity microarray technology for the investigation of active ingredients-target protein recognition strategy. Analytica Chimica Acta 1268:341373

doi: 10.1016/j.aca.2023.341373
[77]

Patterson DM, Nazarova LA, Xie B, Kamber DN, Prescher JA. 2012. Functionalized cyclopropenes as bioorthogonal chemical reporters. Journal of the American Chemical Society 134:18638−18643

doi: 10.1021/ja3060436
[78]

Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. 2002. A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective 'ligation' of azides and terminal alkynes. Angewandte Chemie International Edition 41:2596−2599

doi: 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
[79]

Gao CL, Song JQ, Yang ZN, Wang H, Wu XY, et al. 2024. Chemoproteomics of marine natural product naamidine J unveils CSE1L as a therapeutic target in acute lung injury. Journal of the American Chemical Society 146:28384−28397

doi: 10.1021/jacs.4c09695
[80]

Yang Z, Zhang XW, Zhuo FF, Liu TT, Luo QW, et al. 2023. Allosteric activation of transglutaminase 2 via inducing an 'open' conformation for osteoblast differentiation. Advanced Science 10:e2206533

doi: 10.1002/advs.202206533
[81]

Wijtmans M, de Graaf C, de Kloe G, Istyastono EP, Smit J, et al. 2011. Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity. Journal of Medicinal Chemistry 54:1693−1703

doi: 10.1021/jm1013488
[82]

Cobine PA, Brady DC. 2022. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Molecular Cell 82:1786−1787

doi: 10.1016/j.molcel.2022.05.001
[83]

Kahlson MA, Dixon SJ. 2022. Copper-induced cell death. Science 375:1231−1232

doi: 10.1126/science.abo3959
[84]

Agard NJ, Prescher JA, Bertozzi CR. 2004. A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. Journal of the American Chemical Society 126:15046−15047

doi: 10.1021/ja044996f
[85]

Rojas-Sánchez L, Loza K, Epple M. 2020. Synthesis and intracellular tracing surface-functionalized calcium phosphate nanoparticles by super-resolution microscopy (STORM). Materialia 12:100773

doi: 10.1016/j.mtla.2020.100773
[86]

Ismail HM, Barton V, Phanchana M, Charoensutthivarakul S, Wong MHL, et al. 2016. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7. Proceedings of the National Academy of Sciences of the United States of America 113:2080−2085

doi: 10.1073/pnas.1600459113
[87]

Li L, Zhang Z. 2016. Development and applications of the copper-catalyzed azide-alkyne cycloaddition (CuAAC) as a bioorthogonal reaction. Molecules 21:1393

doi: 10.3390/molecules21101393
[88]

Blackman ML, Royzen M, Fox JM. 2008. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. Journal of the American Chemical Society 130:13518−13519

doi: 10.1021/ja8053805
[89]

Devaraj NK, Weissleder R. 2011. Biomedical applications of tetrazine cycloadditions. Accounts of Chemical Research 44:816−827

doi: 10.1021/ar200037t
[90]

Yi W, Xiao P, Liu X, Zhao Z, Sun X, et al. 2022. Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry. Signal Transduction and Targeted Therapy 7:386

doi: 10.1038/s41392-022-01250-1
[91]

Devaraj N, Hilderbrand S, Upadhyay R, Mazitschek R, Weissleder R. 2010. Bioorthogonal turn-on probes for imaging small molecules inside living cells. Angewandte Chemie International Edition 49:2869−2872

doi: 10.1002/anie.200906120
[92]

Sadakane Y, Hatanaka Y. 2006. Photochemical fishing approaches for identifying target proteins and elucidating the structure of a ligand-binding region using carbene-generating photoreactive probes. Analytical Sciences 22:209−218

doi: 10.2116/analsci.22.209
[93]

Sakurai K, Ozawa S, Yamada R, Yasui T, Mizuno S. 2014. Comparison of the reactivity of carbohydrate photoaffinity probes with different photoreactive groups. ChemBioChem 15:1399−1403

doi: 10.1002/cbic.201402051
[94]

Homan RA, Lapek JD, Woo CM, Niessen S, Jones LH, et al. 2024. Photoaffinity labelling with small molecules. Nature Reviews Methods Primers 4:30

doi: 10.1038/s43586-024-00308-4
[95]

Lapinsky DJ, Johnson DS. 2015. Recent developments and applications of clickable photoprobes in medicinal chemistry and chemical biology. Future Medicinal Chemistry 7:2143−2171

doi: 10.4155/fmc.15.136
[96]

Li T, Wang A, Zhang Y, Chen W, Guo Y, et al. 2024. Chemoproteomic profiling of signaling metabolite fructose-1,6-bisphosphate interacting proteins in living cells. Journal of the American Chemical Society 146:15155−15166

doi: 10.1021/jacs.4c01335
[97]

Gan L, Jiang Q, Huang D, Wu X, Zhu X, et al. 2025. A natural small molecule alleviates liver fibrosis by targeting apolipoprotein L2. Nature Chemical Biology 21:80−90

doi: 10.1038/s41589-024-01704-3
[98]

Chan WC, Zhao Q, Wong KH, Tang HH, Mok DK, et al. 2025. Tetrandrine regulates NAADP-mediated calcium signaling through a LIMP-2-dependent and sphingosine-mediated mechanism. Nature Communications 16:6308

doi: 10.1038/s41467-025-61565-9
[99]

Gao P, Wang J, Qiu C, Zhang H, Wang C, et al. 2024. Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum. iMeta 3:e176

doi: 10.1002/imt2.176
[100]

Ni Z, Shi Y, Liu Q, Wang L, Sun X, et al. 2024. Degradation-based protein profiling: a case study of celastrol. Advanced Science 11:e2308186

doi: 10.1002/advs.202308186
[101]

Chen S, Bi K, Liang H, Wu Z, Huang M, et al. 2024. PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders. Journal of Advanced Research 63:219−230

doi: 10.1016/j.jare.2023.10.014
[102]

Li Y, Zeng ZW, Chen D, Gu ZC, Yan WL, et al. 2023. Facilitated drug repurposing with artemisinin-derived PROTACs: unveiling PCLAF as a therapeutic target. Journal of Medicinal Chemistry 66:11335−11350

doi: 10.1021/acs.jmedchem.3c00824
[103]

Trowbridge AD, Seath CP, Rodriguez-Rivera FP, Li BX, Dul BE, et al. 2022. Small molecule photocatalysis enables drug target identification via energy transfer. Proceedings of the National Academy of Sciences of the United States of America 119:e2208077119

doi: 10.1073/pnas.2208077119
[104]

Buksh BF, Knutson SD, Oakley JV, Bissonnette NB, Oblinsky DG, et al. 2022. μMap-Red: proximity labeling by red light photocatalysis. Journal of the American Chemical Society 144:6154−6162

doi: 10.1021/jacs.2c01384
[105]

Sun Y, Li C, Deng X, Li W, Deng X, et al. 2024. Target protein identification in live cells and organisms with a non-diffusive proximity tagging system. eLife 13:RP102667

doi: 10.7554/eLife.102667.3
[106]

Xiang L, Wang Y, Shao W, Li Q, Yu X, et al. 2025. High-throughput profiling of chemical-induced gene expression across 93,644 perturbations. Nature Methods 22:1954−1963

doi: 10.1038/s41592-025-02781-5
[107]

You Y, Lai X, Pan Y, Zheng H, Vera J, et al. 2022. Artificial intelligence in cancer target identification and drug discovery. Signal Transduction and Targeted Therapy 7:156

doi: 10.1038/s41392-022-00994-0
[108]

Babu M, Snyder M. 2023. Multi-omics profiling for health. Molecular & Cellular Proteomics 22:100561

doi: 10.1016/j.mcpro.2023.100561
[109]

Qiu Y, Cheng F. 2024. Artificial intelligence for drug discovery and development in Alzheimer's disease. Current Opinion in Structural Biology 85:102776

doi: 10.1016/j.sbi.2024.102776
[110]

Ozerov IV, Lezhnina KV, Izumchenko E, Artemov AV, Medintsev S, et al. 2016. In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development. Nature Communications 7:13427

doi: 10.1038/ncomms13427
[111]

Jiang S, Liu K, Jiang T, Li H, Wei X, et al. 2025. Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha. Nature Communications 16:7854

doi: 10.1038/s41467-025-62288-7
[112]

Yu D, Fu S, Wen Z, Song J, Shi L. 2022. Virtual screening of GPX4 agonists in the active ingredients of Artemisia annua. Journal of South China Normal University (Natural Science Edition) 54:59−67

doi: 10.6054/j.jscnun.2022086
[113]

Chen S, Wang Z, Gao J, Wang Y, Liang J, et al. 2025. Rapid discovery of celastrol derivatives as potent and selective PRDX1 inhibitors via microplate-based parallel compound library and in situ screening. Journal of Medicinal Chemistry 68:13609−13627

doi: 10.1021/acs.jmedchem.5c00433
[114]

Li G, Shi Q, Wu Q, Sui X. 2025. Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches. Cancer Biology & Medicine 22:549−597

doi: 10.20892/j.issn.2095-3941.2025.0145
[115]

Reker D, Rodrigues T, Schneider P, Schneider G. 2014. Target prediction by cascaded self-organizing maps for ligand de-orphaning and side-effect investigation. Journal of Cheminformatics 6:P47

doi: 10.1186/1758-2946-6-S1-P47
[116]

Kim Y, Sugihara Y, Kim TY, Cho SM, Kim JY, et al. 2020. Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI. Biomolecules 10:508

doi: 10.3390/biom10040508
[117]

Tabana Y, Babu D, Fahlman R, Siraki AG, Barakat K. 2023. Target identification of small molecules: an overview of the current applications in drug discovery. BMC Biotechnology 23:44

doi: 10.1186/s12896-023-00815-4
[118]

Pasquer QTL, Tsakoumagkos IA, Hoogendoorn S. 2020. From phenotypic hit to chemical probe: chemical biology approaches to elucidate small molecule action in complex biological systems. Molecules 25:5702

doi: 10.3390/molecules25235702
[119]

Zou M, Zhou H, Gu L, Zhang J, Fang L. 2024. Therapeutic target identification and drug discovery driven by chemical proteomics. Biology 13:555

doi: 10.3390/biology13080555
[120]

He SJ, Li J, Zhou JC, Yang ZY, Liu X, et al. 2024. Chemical proteomics accelerates the target discovery of natural products. Biochemical Pharmacology 230:116609

doi: 10.1016/j.bcp.2024.116609
[121]

Chen X, Wang Y, Ma N, Tian J, Shao Y, et al. 2020. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification. Signal Transduction and Targeted Therapy 5:72

doi: 10.1038/s41392-020-0186-y
[122]

Chen J, Guo Y, Shao J, Guo M, Zhu X. 2025. Target fishing: from 'needle in haystack' to 'precise guidance' − new technology, new strategy and new opportunity. Frontiers in Pharmacology 16:1673688

doi: 10.3389/fphar.2025.1673688
[123]

Zhang HW, Lv C, Zhang LJ, Guo X, Shen YW, et al. 2021. Application of omics- and multi-omics-based techniques for natural product target discovery. Biomedicine & Pharmacotherapy 141:111833

doi: 10.1016/j.biopha.2021.111833
[124]

Chen C, Wang J, Pan D, Wang X, Xu Y, et al. 2023. Applications of multi-omics analysis in human diseases. MedComm 4:e315

doi: 10.1002/mco2.315
[125]

Zhang P, Zhang D, Zhou W, Wang L, Wang B, et al. 2023. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Briefings in Bioinformatics 25:bbad518

doi: 10.1093/bib/bbad518